Overview Of qPCR and dPCR Instrumentation Market
Real-time PCR or quantitative PCR is a well-established technology that has become the tool of choice for the rapid, sensitive quantification of nucleic acid in various biological samples. qPCR measures the accumulation of DNA during a PCR reaction. The increase in quantity of DNA at each cycle is measured by the change in intensity of a fluorescent signal. Comparison to a reference sample determines the number of original copies of template DNA in the reaction.
Digital PCR is a highly precise approach to sensitive nucleic acid detection and quantification. Each sample is partitioned into thousands of individual reactions (droplets for Droplet Digital™ PCR technology). Each partition is analyzed after end-point PCR cycling for the presence or absence of a fluorescent signal, and the absolute number of molecules present in the sample is calculated. dPCR does not require a standard curve for quantification.
Both quantitative PCR (qPCR) and digital PCR (dPCR) provide sensitive and specific detection, and precise quantification of nucleic acids. Both technologies have similarities, but they have differences that make one or the other the more adapted choice for specific applications. The new market research report qPCR and dPCR Instrumentation Market to its huge collection of research reports. qPCR and dPCR Instrumentation market and delivers a comprehensive individual analysis on the top companies, including Thermo Fisher, Roche, QIAGEN, Bio-rad, Agilent, Bioer, Biosynex, Esco, Analytik Jena, Techne, Fluidigm, RainDance Technologies
The global qPCR and dPCR Instrumentation market is estimated to be valued at USDXX Million in the year 2028, growing at a CAGR of XX% in the period 2021 to 2028.
The qPCR and dPCR Instrumentation market report offers in-depth and extensive analysis of the factors affecting Market Dynamics, Distribution Channel, Product type, and geography, emerging technological trends, market challenges, recent industrial policies, and market size, revenue share and detailed forecasts during 2021-2028. It also provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the revenue forecasts for global, regional and country levels.
Key Companies
Thermo Fisher
Roche
QIAGEN
Bio-rad
Agilent
Bioer
Biosynex
Esco
Analytik Jena
Techne
Fluidigm
RainDance Technologies
Market Product Type Segmentation
dPCR
qPCR
Market by Application Segmentation
Clinical Use
Research Use
Other
By Region
Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America [United States, Canada, Mexico]
Middle East & Africa [GCC, North Africa, South Africa]
South America [Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the size of occupied by the prominent leaders for the forecast period, 2021 to 2028?
• What will be the share and the growth rate of the qPCR and dPCR Instrumentation market during the forecast period?
• What are the future prospects for the qPCR and dPCR Instrumentation industry in the coming years?
• Which trends are likely to contribute to the development rate of the industry during the forecast period, 2021 to 2028?
• What are the future prospects of the qPCR and dPCR Instrumentation industry for the forecast period, 2021 to 2028?
• Which companies are dominating the competitive landscape across different region and what strategies have they applied to gain a competitive edge?
• What are the major factors responsible for the growth of the market across the different regions?
• What are the challenges faced by the companies operating in the qPCR and dPCR Instrumentation market?
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.